Document is current

Article History

Received: 25 March 2026

Accepted: 5 May 2026

First Online: 14 May 2026

Declarations

:

: Ghezzi Angelo is an Editorial Board member of Neurology and Therapy . Angelo Ghezzi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Pozzato Mattia received honoraria for lecturing and/or travel expenses for attending congresses and meetings from Alexion, Amgen, Biogen, Bristol Meyer Squibb, Janssen, Juvisè, Lundbeck, Merck, Novartis, Neuraxpharm, Roche and Sanofi-Genzyme. Annovazzi Pietro received honoraria for lecturing and participation in advisory boards, and/or travel expenses for attending congresses and meetings from Alexion, Almirall, Amgen, Biogen, Bristol Meyer Squibb, Janssen, Juvisè, Lundbeck, Merck, Novartis, Neuraxpharm, Roche, Sanofi-Genzyme and Viatris. Antozzi Carlo received funding for travel, meeting attendance and advisory board participation from Alexion, Momenta, argenx, UCB and Johnson & Johnson. Erbetta Alessandra has nothing to disclose. Torri Clerici Valentina acted as an Advisory Board member of Neuraxapharm, Lundbeck, Amgen, Novartis, Merck, Roche, Sanofi and Almirall and received funding for traveling and honoraria for speaking or writing from Biogen, Novartis, Sanofi, Merck, Amgen, Roche, Alexion, Neuraxapharm, Janssen, Bristol Meyer Squibb and Almirall. She received support for research project by Almirall.

: The patient gave her consent to publish data concerning her clinical history.